Phase 1/2 Study of Linvoseltamab in Adult Patients With Relapsed or Refractory Multiple Myeloma
Recruiting now · Phase 1/Phase 2
Conditions studied: Multiple Myeloma
In brief
The main purpose of this study is to learn about the safety of linvoseltamab and to find out what is the best dose of linvoseltamab to give to patients with multiple myeloma and to look for any signs that linvoseltamab can effectively treat cancer. The study is looking at several other research questions, including: * Side effects that may be experienced by people receiving linvoseltamab * How linvoseltamab works in the body * How much linvoseltamab is present in the blood * How linvoseltamab may work to treat cancer
Key facts
- Study ID
- NCT03761108
- Run by
- Regeneron Pharmaceuticals
- People needed
- 387
- Starts
- 2019-01-23
- Expected to finish
- 2033-06-16
- Last updated by the study team
- 2026-04-20
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Tokushima Prefectural Central Hospital — Tokushima, Tokushima, Japan (enrolling)
- Moffitt Cancer Center - McKinley Drive — Tampa, Florida, United States (enrolling)
- Keio University Hospital — Tokyo, Japan (enrolling)
- National Cancer Center Korea — Goyang, South Korea (enrolling)
- Seoul National University Cancer Hospital — Seoul, South Korea (enrolling)
- The Catholic University of Korea, Seoul St. Mary's Hospital — Seoul, South Korea (enrolling)
- Yonsei University College of Medicine, Severance Hospital — Seoul, South Korea (enrolling)
- Hospital de la Santa Creu i Sant Pau — Barcelona, Catalonia, Spain (enrolling)
- Clinica Universidad de Navarra — Pamplona, Navarre, Spain (enrolling)
- Universitary Hospital La Princesa — Madrid, Salamanca, Spain (enrolling)
- Hospital Universitario Ramon y Cajal — Madrid, Spain (enrolling)
- Hospital Universitario 12 de Octubre — Madrid, Spain (enrolling)
- Hospital Clinico Universitario de Salamanca — Salamanca, Spain (enrolling)
- Swedish Cancer Institute — Seattle, Washington, United States (enrolling)
- ZNA Psychiatrisch Ziekenhuis Stuivenberg — Antwerp, Belgium (enrolling)
- Cliniques Universitaires Saint-Luc — Brussels, Belgium (enrolling)
- Norton Cancer Institute — Louisville, Kentucky, United States (enrolling)
- Icahn School of Medicine at Mount Sinai — New York, New York, United States (enrolling)
- Emory University Hospital — Atlanta, Georgia, United States (enrolling)
- Ohio State University James Cancer Hospital — Columbus, Ohio, United States (enrolling)
- Nagoya City University Hospital — Nagoya, Aichi-ken, Japan (enrolling)
- National Cancer Center Hospital East — Kashiwa-shi, Chiba, Japan (enrolling)
- Gunma University Hospital — Maebashi, Gunma, Japan (enrolling)
- Ibaraki Prefectural Central Hospital — Kasama-shi, Ibaraki, Japan (enrolling)
- University Hospital Kyoto Prefectural Univ of Medicine — Kyoto, Kyoto, Japan (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.